DEF: Waystar 2026 Proxy Statement and 2025 Performance

Waystar Holding Corp. reports strong 2025 financial performance, surpassing $1 billion in revenue, and outlines governance and compensation updates ahead of its 2026 Annual Meeting.

Summary

• Waystar achieved over $1 billion in annual revenue for the first time in 2025, representing 17% year-over-year growth.
• The company reported 2025 net income of $112.1 million with a 10% margin.
• Adjusted EBITDA for 2025 reached $462.1 million, reflecting a 42% margin.
• The company completed the acquisition of Iodine Software in 2025 to expand into clinical mid-cycle solutions.
• Waystar launched 'AltitudeAI', an AI-powered suite that reportedly prevented $15 billion in denials and drove $2.4 billion in reimbursement impact.
• The 2026 Annual Meeting is scheduled for June 1, 2026, to be held virtually.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive filing, highlighting strong financial growth, successful strategic acquisitions, and a clear, technology-focused roadmap for future expansion.

Positives

• Revenue grew 17% year-over-year to $1.1 billion.
• Adjusted EBITDA margin remained strong at 42%.
• Net revenue retention rate reached 112%, indicating strong client satisfaction and expansion.
• Successful acquisition and integration of Iodine Software.
• Refinanced first lien credit facility, enhancing financial flexibility.

Negatives

• Chief Technology Officer Christopher L. Schremser announced his resignation effective June 12, 2026.
• Several executive officers and directors had delinquent Section 16(a) filings during 2025.

Risks

• Cybersecurity and data privacy risks, given the company's role in processing sensitive healthcare and payment data.
• Dependence on the performance of new product offerings like Waystar AltitudeAI.
• Risks associated with the integration of acquired businesses, specifically Iodine Software.
• Potential for regulatory changes in healthcare and data privacy laws.
• Market competition and the need for continuous innovation in AI-driven revenue cycle automation.

Future Outlook

Waystar aims to lead the next era of healthcare revenue cycle automation by building a fully autonomous revenue cycle platform. The company plans to continue leveraging its proprietary data, network, and AI capabilities to drive growth and efficiency.

Management Comments

• Waystar surpassed $1 billion in annual revenue for the first time, a milestone that reflects the strength of our platform, the durability of our strategy, and the dedication of our team.
• Our mission to simplify healthcare payments has never been more relevant as providers navigate increasing administrative complexity across the healthcare system.
• Looking ahead, we believe Waystar is well positioned to lead the next era of healthcare revenue cycle automation.

Industry Context

StockSavvy.ai notes that Waystar is operating in a highly competitive healthcare technology sector, where AI-driven automation is becoming a critical differentiator for revenue cycle management providers. The company's focus on 'autonomous' workflows aligns with broader industry trends toward reducing administrative burden and improving financial outcomes for healthcare providers.

Comparison to Industry Standards

• Waystar's 2025 revenue growth of 17% and 42% Adjusted EBITDA margin compare favorably to its peer group of healthcare technology and SaaS companies.
• The company's market capitalization post-IPO is above the peer group median.
• Waystar's one-year Total Shareholder Return (TSR) has outperformed most of its peer companies.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed.

Related Party Transactions

• The company has commercial transactions with entities affiliated with Bain and CPPIB, including Aveanna Healthcare, Surgery Partners, and others.
• Affiliates of Bain and CPPIB are lenders under the company's First Lien Credit Facility.

Stakeholder Impact

• Shareholders are asked to vote on director elections, auditor ratification, and the frequency of future executive compensation votes.
• Employees are subject to updated AI use policies and mandatory training.
• Clients benefit from the integration of Iodine Software and the launch of Waystar AltitudeAI.

Next Steps

• Hold 2026 Annual Meeting of Stockholders on June 1, 2026.
• Elect four Class II directors.
• Ratify the appointment of KPMG LLP as independent auditor for 2026.
• Conduct advisory vote on the frequency of future Say-on-Pay votes.

Key Dates

Recommendation

The company is performing well financially and executing on its strategic roadmap, but the upcoming departure of the CTO and the transition to a new equity compensation structure suggest a period of internal adjustment that warrants a hold position until further stability is demonstrated.

Keywords

Waystar, Healthcare Payments, Revenue Cycle Management, AI, Healthcare Technology, Proxy Statement, SEC Filing